Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis.

Autor:	Bernacchioni C; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy. Electronic address: caterina.bernacchioni@unifi.it., Rossi M; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy., Vannuzzi V; Obstetrics and Gynecology, Careggi University Hospital, Florence, Italy., Prisinzano M; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy., Seidita I; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy., Raeispour M; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy., Muccilli A; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy., Castiglione F; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy., Bruni P; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy., Petraglia F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy; Obstetrics and Gynecology, Careggi University Hospital, Florence, Italy., Donati C; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio,' University of Florence, Florence, Italy.
Jazyk:	angličtina
Zdroj:	Fertility and sterility [Fertil Steril] 2024 Apr; Vol. 121 (4), pp. 631-641. Date of Electronic Publication: 2023 Dec 08.
DOI:	10.1016/j.fertnstert.2023.12.007
Abstrakt:	Objective: To study the molecular mechanisms responsible for fibrosis in endometriosis by investigating whether the protein expression levels of sphingosine-1-phosphate receptor 3 (S1PR3), one of the five specific receptors of the bioactive sphingolipid sphingosine-1-phosphate (S1P), correlate with fibrosis extent in endometriotic lesions and which are the cellular mechanisms involved in this process. Design: Case-control laboratory study and cultured endometriotic cells. Setting: University research institute and university hospital. Patient(s): A total of 33 women, with and without endometriosis, were included in the study. Interventions(s): Endometriotic lesions were obtained from women with endometriosis (ovarian endometrioma, n = 8; deep infiltrating endometriosis, n = 15; [urological n = 5, gastrointestinal n = 6, and posterior n = 4]) and control endometrium from healthy women, n = 10, by means of laparoscopic and hysteroscopic surgery. The expression of S1PR3 was evaluated using immunohistochemistry and the extent of fibrosis was assessed using Masson's trichrome staining. Human-cultured epithelial endometriotic 12Z cells were used to evaluate the mechanisms involved in the profibrotic effect of S1PR3 activation. Main Outcome Measure(s): The expression of S1PR3 in endometriotic lesions is positively correlated with endometriosis-associated fibrosis. In addition, S1P induced epithelial-mesenchymal transition (EMT) and fibrosis in epithelial endometriotic cells. Using RNA interference and pharmacological approaches, the profibrotic effect of S1P was shown to rely on S1PR3, thus unveiling the molecular mechanism implicated in the profibrotic action of the bioactive sphingolipid. Result(s): The protein expression levels of S1PR3 were significantly augmented in the glandular sections of endometrioma and deep infiltrating endometriosis of different localizations with respect to the control endometrium and positively correlated with the extent of fibrosis. Sphingosine-1-phosphate was shown to have a crucial role in the onset of fibrosis in epithelial endometriotic cells, stimulating the expression of EMT and fibrotic markers. Genetic approaches have highlighted that S1PR3 mediates the fibrotic effect of S1P. Downstream of S1PR3, ezrin and extracellular-signal-regulated kinases 1 and 2 signaling were found to be critically implicated in the EMT and fibrosis elicited by S1P. Conclusion(s): Sphingosine-1-phosphate receptor 3 may represent a possible innovative pharmacological target for endometriosis. Competing Interests: Declaration of Interests C.B. has nothing to disclose. M. Rossi has nothing to disclose. V.V. has nothing to disclose. M.P. has nothing to disclose. I.S. has nothing to disclose. M. Raeispour has nothing to disclose. A.M. has nothing to disclose. F.C. has nothing to disclose. P.B. has nothing to disclose. F.P. has nothing to disclose. C.D. has nothing to disclose. (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu